Triple therapy in COPD: understanding the data
Samy Suissa
Abstract
<b>Effectiveness of single-inhaler triple therapy on exacerbation risk and mortality in COPD is exaggerated in IMPACT and ETHOS trials from confounding by prior ICS discontinuation: effectiveness fades in analyses and studies with no prior ICS discontinuation</b>https://bit.ly/3tOgNdW
Topics & Concepts
MedicineDiscontinuationCOPDExacerbationConfoundingInhalerIntensive care medicineInternal medicineAsthmaChronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory and Cough-Related ResearchInhalation and Respiratory Drug Delivery